Cargando…
Dysfunction of miR‐802 in tumors
Recent studies have shown that miR‐802 is abnormally expressed in many tumors. miR‐802 is expressed at low levels in tissues and cells of gastric cancer, colorectal cancer, breast cancer, cervical cancer, epithelial ovarian cancer, tongue squamous cell carcinoma, oral squamous cell carcinoma, esopha...
Autores principales: | Gao, Tong, Zou, Mengsha, Shen, Tiancheng, Duan, Shiwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8605121/ https://www.ncbi.nlm.nih.gov/pubmed/34558723 http://dx.doi.org/10.1002/jcla.23989 |
Ejemplares similares
-
Dysfunction and ceRNA network of the tumor suppressor miR-637 in cancer development and prognosis
por: Shen, Jinze, et al.
Publicado: (2022) -
Regulation of the small GTPase Ran by miR-802 modulates proliferation and metastasis in colorectal cancer cells
por: Wang, Xin, et al.
Publicado: (2020) -
The tumor suppressor role and ceRNA network of miR-1294 in cancer
por: MAO, YUNAN, et al.
Publicado: (2023) -
Obesity-induced overexpression of miR-802 impairs insulin transcription and secretion
por: Zhang, Fangfang, et al.
Publicado: (2020) -
miR-802 participates in the inflammatory process of inflammatory bowel disease by suppressing SOCS5
por: Yao, Jun, et al.
Publicado: (2020)